【佰泽医疗(02609.HK)港股首秀暴涨42% 肿瘤康复共识助力行业升级】智通财经APP获悉,6月23日,中国肿瘤医疗

智通财经
26 Jun
【佰泽医疗(02609.HK)港股首秀暴涨42% 肿瘤康复共识助力行业升级】智通财经APP获悉,6月23日,中国肿瘤医疗服务领域的璀璨新星——佰泽医疗(02609.HK)正式敲响港交所的上市锣声,迎来资本市场首秀。上市首日,公司股价高开近25%,一路高歌猛进,收盘大涨超42%,报收6.00港元,展现出市场对其发展前景的强烈信心。此次IPO,佰泽医疗以4.22港元的发行价,发行了1.33亿股,成功募集到了约5.62亿港元的资金,为后续的发展注入了强大的动力。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10